We are live on
!
Find out more
PC
Polar Capital Portfolio holdings
AUM
$13.5B
1-Year Est. Return
55.9%
This Fund
S&P 500
This Quarter
Est. Return
+20.52%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$10.8B
AUM Growth
+$1.42B
(+15%)
Cap. Flow
-$217M
Cap. Flow
% of AUM
-2.01%
Top 10 Holdings %
Top 10 Hldgs %
22.86%
Holding
302
New
45
Increased
79
Reduced
106
Closed
36
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$73.2M |
| 2 |
Synopsys
SNPS
|
+$63.3M |
| 3 |
Global Payments
GPN
|
+$55.9M |
| 4 |
Teleflex
TFX
|
+$54.3M |
| 5 |
Agilent Technologies
A
|
+$47.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$160M |
| 2 |
UnitedHealth
UNH
|
+$122M |
| 3 |
Medtronic
MDT
|
+$90M |
| 4 |
Humana
HUM
|
+$52M |
| 5 |
LOXO
Loxo Oncology, Inc
LOXO
|
+$50M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.76% |
| 2 | Financials | 21.83% |
| 3 | Healthcare | 19.84% |
| 4 | Communication Services | 8.39% |
| 5 | Consumer Discretionary | 7.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DESP
226
DELISTED
Despegar.com
DESP
| $1.69M | 0.02% |
113,097
| – | – |
|
|
OBSV
227
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $1.16M | 0.01% |
90,290
-84,710
| -48% | -$1.09M |
|
|
IMMP
228
Immutep
IMMP
$56.1M
| $1.09M | 0.01% |
500,000
| – | – |
|
229
Lyft
LYFT
$5.86B
| $979K | 0.01% |
+12,500
| New | +$979K |
|
|
VNET
230
VNET Group
VNET
$1.79B
| $918K | 0.01% |
115,674
+45,007
| +64% | +$403K |
|
231
Fate Therapeutics
FATE
$275M
| $778K | 0.01% |
+44,300
| New | +$699K |
|
232
NetEase
NTES
$83B
| $736K | 0.01% |
15,240
+2,270
| +18% | +$108K |
|
|
JOBS
233
DELISTED
51job Inc
JOBS
| $689K | 0.01% |
8,850
-2,722
| -24% | -$189K |
|
|
VRNA
234
DELISTED
Verona Pharma
VRNA
| $650K | 0.01% |
100,000
| – | – |
|
235
Summit Therapeutics
SMMT
$10.2B
| $641K | 0.01% |
350,000
| – | – |
|
236
Shopify
SHOP
$168B
| $620K | 0.01% |
+30,000
| New | +$530K |
|
|
VIVE
237
DELISTED
VIVEVE MED INC
VIVE
| $566K | 0.01% |
603
-109
| -15% | -$116K |
|
238
NovaGold Resources
NG
$2.54B
| $529K | ﹤0.01% |
126,946
| – | – |
|
|
NBIS
239
Nebius Group N.V.
NBIS
$37.6B
| $481K | ﹤0.01% |
+14,016
| New | +$465K |
|
|
FENG
240
Phoenix New Media
FENG
$17.5M
| $440K | ﹤0.01% |
17,426
-14,060
| -45% | -$320K |
|
241
Esquire Financial Holdings
ESQ
$1.14B
| $401K | ﹤0.01% |
17,638
-12,447
| -41% | -$279K |
|
242
Texas Capital Bancshares
TCBI
$4.28B
| $347K | ﹤0.01% |
6,360
+295
| +5% | +$17.1K |
|
243
Goldman Sachs
GS
$289B
| $249K | ﹤0.01% |
1,298
-339
| -21% | -$65.4K |
|
244
CALL
Apple
AAPL
$4.97T
| – | – |
-29,200
| Closed | -$7K |
|
245
CALL
Advanced Micro Devices
AMD
$700B
| – | – |
-15,450
| Closed | -$15K |
|
246
Amgen
AMGN
$209B
| – | – |
-101,075
| Closed | -$19.7M |
|
247
Amphenol
APH
$185B
| – | – |
-94,588
| Closed | -$1.92M |
|
248
Biogen
BIIB
$30.9B
| – | – |
-50,000
| Closed | -$15M |
|
249
CVS Health
CVS
$135B
| – | – |
-275,000
| Closed | -$18M |
|
250
Quest Diagnostics
DGX
$26B
| – | – |
-149,254
| Closed | -$12.4M |
|
Similar funds
ECM
FAAS
WAM
FS
NIMC
TI
VIM
PS
Polar Capital's Q1 2019 Portfolio in Review
As of Q1 2019, Polar Capital held 302 positions worth $10.8B, up 15% from $9.35B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Polar Capital's Q1 2019 filing shows 45 new, 79 increased, 106 reduced and 36 closed positions. Its largest new stake was Global Payments: 460,457 shares worth $62.9M. The largest sale was Johnson & Johnson, an estimated $160M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.
- Polar Capital's largest Q1 2019 buy was Global Payments: 460,457 shares worth $62.9M.
- Polar Capital added most to Merck in Q1 2019, an estimated $73.2M increase.
- Polar Capital's biggest Q1 2019 reduction was Johnson & Johnson, cutting an estimated $160M.
- Polar Capital fully exited UnitedHealth in Q1 2019, selling an estimated $122M.
- Polar Capital's ten largest holdings make up 23% of its $10.8B portfolio in Q1 2019.
- Polar Capital opened 45 new positions and closed 36 in Q1 2019.
- Polar Capital's portfolio value rose 15% quarter-over-quarter to $10.8B.
Based on Polar Capital's 13F filing for Q1 2019, filed 15 May 2019.